Anti-angiogenic therapy for lung cancer

Pavlakis, Nick, Marx, Gavin, White, Shane, Lee, Christopher W. and Khasraw, Mustafa 2010, Anti-angiogenic therapy for lung cancer, Cochrane database of systematic reviews, no. 4, doi: 10.1002/14651858.CD008047.

Attached Files
Name Description MIMEType Size Downloads

Title Anti-angiogenic therapy for lung cancer
Author(s) Pavlakis, Nick
Marx, Gavin
White, Shane
Lee, Christopher W.
Khasraw, MustafaORCID iD for Khasraw, Mustafa
Journal name Cochrane database of systematic reviews
Issue number 4
Total pages 8
Publisher John Wiley & Sons
Place of publication Oxford, England
Publication date 2010
ISSN 1469-493X
Keyword(s) angiogenesis
lung cancer
Summary This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the benefits and harms of angiogenesis inhibitors in the treatment of lung cancer when given alone, following or in combination with chemotherapy or chemo-radiotherapy (in the case of locally advanced non-metastatic NSCLC or limited stage SCLC).
Language eng
DOI 10.1002/14651858.CD008047
Field of Research 119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©2010, The Cochrane Collaboration
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 482 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Tue, 31 Jul 2012, 12:24:54 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact